Thorlacius S - Search Results

1

Population-based study of risk of breast cancer in carriers of BRCA2 mutation.

Thorlacius S, Struewing JP, Hartge P, Olafsdottir GH, Sigvaldason H, Tryggvadottir L, Wacholder S, Tulinius H, Eyfjörd JE. Thorlacius S, et al. Lancet. 1998 Oct 24;352(9137):1337-9. doi: 10.1016/s0140-6736(98)03300-5. Lancet. 1998. PMID: 9802270

2

BRCA2 mutation carriers, reproductive factors and breast cancer risk.

Tryggvadottir L, Olafsdottir EJ, Gudlaugsdottir S, Thorlacius S, Jonasson JG, Tulinius H, Eyfjord JE. Tryggvadottir L, et al. Among authors: thorlacius s. Breast Cancer Res. 2003;5(5):R121-8. doi: 10.1186/bcr619. Epub 2003 Jun 24. Breast Cancer Res. 2003. PMID: 12927042 Free PMC article.

3

Prostate cancer progression and survival in BRCA2 mutation carriers.

Tryggvadóttir L, Vidarsdóttir L, Thorgeirsson T, Jonasson JG, Olafsdóttir EJ, Olafsdóttir GH, Rafnar T, Thorlacius S, Jonsson E, Eyfjord JE, Tulinius H. Tryggvadóttir L, et al. Among authors: thorlacius s. J Natl Cancer Inst. 2007 Jun 20;99(12):929-35. doi: 10.1093/jnci/djm005. Epub 2007 Jun 12. J Natl Cancer Inst. 2007. PMID: 17565157

4

Genetic changes in breast carcinomas in an Icelandic population.

Eyfjörd JE, Thorlacius S. Eyfjörd JE, et al. Among authors: thorlacius s. Pharmacogenetics. 1992 Dec;2(6):309-16. doi: 10.1097/00008571-199212000-00010. Pharmacogenetics. 1992. PMID: 1306132

5

Linkage to BRCA2 region in hereditary male breast cancer.

Thorlacius S, Tryggvadottir L, Olafsdottir GH, Jonasson JG, Ogmundsdottir HM, Tulinius H, Eyfjord JE. Thorlacius S, et al. Lancet. 1995 Aug 26;346(8974):544-5. doi: 10.1016/s0140-6736(95)91383-1. Lancet. 1995. PMID: 7658781

6

Male breast cancer in Iceland.

Jonasson JG, Agnarsson BA, Thorlacius S, Eyfjord JE, Tulinius H. Jonasson JG, et al. Among authors: thorlacius s. Int J Cancer. 1996 Feb 8;65(4):446-9. doi: 10.1002/(SICI)1097-0215(19960208)65:4<446::AID-IJC9>3.0.CO;2-X. Int J Cancer. 1996. PMID: 8621225 Free article.

7

A single BRCA2 mutation in male and female breast cancer families from Iceland with varied cancer phenotypes.

Thorlacius S, Olafsdottir G, Tryggvadottir L, Neuhausen S, Jonasson JG, Tavtigian SV, Tulinius H, Ogmundsdottir HM, Eyfjörd JE. Thorlacius S, et al. Nat Genet. 1996 May;13(1):117-9. doi: 10.1038/ng0596-117. Nat Genet. 1996. PMID: 8673089

8

Study of a single BRCA2 mutation with high carrier frequency in a small population.

Thorlacius S, Sigurdsson S, Bjarnadottir H, Olafsdottir G, Jonasson JG, Tryggvadottir L, Tulinius H, Eyfjörd JE. Thorlacius S, et al. Am J Hum Genet. 1997 May;60(5):1079-84. Am J Hum Genet. 1997. PMID: 9150155 Free PMC article.

9

BRCA2 mutation in Icelandic prostate cancer patients.

Sigurdsson S, Thorlacius S, Tomasson J, Tryggvadottir L, Benediktsdottir K, Eyfjörd JE, Jonsson E. Sigurdsson S, et al. Among authors: thorlacius s. J Mol Med (Berl). 1997 Oct;75(10):758-61. doi: 10.1007/s001090050162. J Mol Med (Berl). 1997. PMID: 9383000

10

BRCA2 and p53 mutations in primary breast cancer in relation to genetic instability.

Gretarsdottir S, Thorlacius S, Valgardsdottir R, Gudlaugsdottir S, Sigurdsson S, Steinarsdottir M, Jonasson JG, Anamthawat-Jonsson K, Eyfjörd JE. Gretarsdottir S, et al. Among authors: thorlacius s. Cancer Res. 1998 Mar 1;58(5):859-62. Cancer Res. 1998. PMID: 9500438

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

80 results

Search Page